The UK-US pharma deal removes tariffs, boosts NHS access to innovative medicines, and drives significant life-sciences investment, safeguarding patients and industry growth.
Researchers have identified 140 genes that could change how non-small cell lung cancer (NSCLC) patients are treated with immunotherapy and low-dose radiation.
The Food and Drug Administration (FDA) has an approach for the expanded use of Omalizumab (Xolair), to address allergic reactions, including anaphylaxis, stemming from accidental exposure to various foods.
Researchers from Amsterdam UNC and Radboundumc have revealed a method to predict the effectiveness of antidepressants within a week of treatment
This advancement powered by...
Biologic therapies can effectively control severe asthma without the need for regular high-dose inhaled steroids, a significant revelation that could transform the lives of millions grappling with the condition.
A new Artificial intelligence (AI) system has been designed to examine specialised brain MRIs and proved accurate in diagnosing autism in children aged 24 to 48 months.
